Foghorn Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -161.0% | – | – | |
| – | +82.8% | +91.5% | +143.2% | +144.8% | -56.3% | -9.6% | +6.8% | |
| – | +131.4% | +74.8% | +183.1% | +71.0% | +12.9% | -26.5% | -12.6% | |
| – | +227.7% | +157.8% | +32.7% | +44.4% | – | – | – | |
| – | -50.6% | +2,297.9% | +16.5% | +741.9% | -114.9% | – | – | |
| – | -37.2% | +1,571.8% | -79.5% | -63.5% | +1.2% | -26.0% | -94.5% | |
| – | -37.4% | +11,198.1% | – | -775.4% | – | -120.7% | – | |
| – | – | – | -64.6% | -96.0% | – | – | – | |
| – | -28.3% | -46.5% | -596.6% | -100.0% | – | – | – | |
| – | -53.7% | +807.3% | -89.7% | -92.1% | +0.9% | +5,829.6% | -99.0% | |
| – | -184.6% | – | -89.2% | -686.5% | – | -188.5% | – | |
| – | – | – | – | – | -162.0% | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.